Conmed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Conmed and other ETFs, options, and stocks.

About CNMD

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. 

CEO
Patrick Joseph Beyer
CEOPatrick Joseph Beyer
Employees
3,900
Employees3,900
Headquarters
Largo, Florida
HeadquartersLargo, Florida
Founded
1970
Founded1970
Employees
3,900
Employees3,900

CNMD Key Statistics

Market cap
1.10B
Market cap1.10B
Price-Earnings ratio
20.24
Price-Earnings ratio20.24
Dividend yield
2.23%
Dividend yield2.23%
Average volume
505.31K
Average volume505.31K
High today
$36.86
High today$36.86
Low today
$35.59
Low today$35.59
Open price
$36.20
Open price$36.20
Volume
403.65K
Volume403.65K
52 Week high
$61.08
52 Week high$61.08
52 Week low
$33.21
52 Week low$33.21

Stock Snapshot

Conmed(CNMD) stock is priced at $36.61, giving the company a market capitalization of 1.1B. It carries a P/E multiple of 20.24 and pays a dividend yield of 2.2%.

On 2026-05-06, Conmed(CNMD) stock moved within a range of $35.59 to $36.86. With shares now at $36.61, the stock is trading +2.9% above its intraday low and -0.7% below the session's peak.

Trading volume for Conmed(CNMD) stock has reached 403.65K, versus its average volume of 505.31K.

The stock's 52-week range extends from a low of $33.21 to a high of $61.08.

The stock's 52-week range extends from a low of $33.21 to a high of $61.08.

CNMD News

TipRanks 5d
Conmed Earnings Call Balances Headwinds With Guidance

Conmed Corporation ((CNMD)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and...

Nasdaq 6d
Conmed Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Conmed Q1 2026 Earnings Transcript
TipRanks 6d
Michael Matson Reiterates Hold on Conmed as Slowing Organic Growth and Margin Pressure Offset 1Q26 Beat; Price Target Raised to $35.96

In a report released today, Michael Matson from Needham maintained a Hold rating on Conmed, with a price target of $35.96. Unlock hedge fund-level data and pow...

Analyst ratings

100%

of 6 ratings
Buy
0%
Hold
100%
Sell
0%

More CNMD News

Seeking Alpha 6d
Conmed projects 2026 organic growth of 5.0% to 6.5% while refinancing debt and exiting GI

Earnings Call Insights Conmed projects 2026 organic growth of 5.0% to 6.5% while refinancing debt and exiting GI Apr 30, 2026, 12:53 AM ET CONMED Corporation (C...

Conmed projects 2026 organic growth of 5.0% to 6.5% while refinancing debt and exiting GI
TipRanks 7d
Conmed reports Q1 EPS 89c, consensus 82c

Reports Q1 revenue $317.0M, consensus $310.6M. “Our 2025 momentum continued in the first quarter as we delivered revenue and adjusted earnings ahead of our expe...

People also own

Based on the portfolios of people who own CNMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.